Changes

m
no edit summary
Line 148: Line 148:  
|6
 
|6
 
|Abnormality
 
|Abnormality
|gain of 6p, loss of 6q <ref>{{Cite journal|last=Dearden|first=Claire|date=2012-07-19|title=How I treat prolymphocytic leukemia|url=https://pubmed.ncbi.nlm.nih.gov/22649104|journal=Blood|volume=120|issue=3|pages=538–551|doi=10.1182/blood-2012-01-380139|issn=1528-0020|pmid=22649104}}</ref>
+
|gain of 6p, loss of 6q <ref>{{Cite journal|last=Dearden|first=Claire|date=2012-07-19|title=How I treat prolymphocytic leukemia|url=https://pubmed.ncbi.nlm.nih.gov/22649104|journal=Blood|volume=120|issue=3|pages=538–551|doi=10.1182/blood-2012-01-380139|issn=1528-0020|pmid=22649104}}</ref><ref>{{Cite journal|last=Soulier|first=J.|last2=Pierron|first2=G.|last3=Vecchione|first3=D.|last4=Garand|first4=R.|last5=Brizard|first5=F.|last6=Sigaux|first6=F.|last7=Stern|first7=M. H.|last8=Aurias|first8=A.|date=2001-07|title=A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia|url=https://pubmed.ncbi.nlm.nih.gov/11391795|journal=Genes, Chromosomes & Cancer|volume=31|issue=3|pages=248–254|doi=10.1002/gcc.1141|issn=1045-2257|pmid=11391795}}</ref>
 
|
 
|
 
|No
 
|No